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S U M M A R Y
Objectives: The proportion of very elderly people in the population is increasing, and infectious diseases
in this patient group may present with speciﬁc characteristics. The objective of this study was to
investigate the outcome predictors of bacteremia among the very elderly.
Methods: This was a multicenter prospective cohort study of bloodstream infections (BSI) in patients
80 years old in 15 hospitals in Spain. The outcome variables were 14-day and 30-day mortality.
Multivariate analysis was performed.
Results: One hundred and twenty episodes were included. Mortality was 22% (n = 26) on day 14 and 28%
(n = 34) on day 30. In the univariate analysis, the variables associated with mortality were neutropenia,
recent surgery, Pitt score 2, intensive care unit (ICU) admission, severe sepsis or shock, and abdominal,
unknown, and respiratory tract sources. In the multivariate analysis, variables associated with mortality on
day 14 were high-risk source (abdominal, unknown, and respiratory tract sources; odds ratio (OR) 7.9, 95%
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(OR 11.24, 95% CI 1.6–80.2), and severe sepsis or shock at presentation (OR 5.3, 95% CI 1.4–20.7); the
interaction between empiric treatment and high-risk source was signiﬁcant. On day 30, mortality was
independently related to a high-risk source (OR 2.92, 95% CI 1.1–7.5) and presentation with severe sepsis or
shock (OR 3.81, 95% CI 1.2–12.4).
Conclusions: Presentation with severe sepsis or shock and a high-risk source of BSI were independent
predictors of 14-day and 30-day mortality. Inadequate empirical treatment was also a predictor of early
mortality in patients with a high-risk source.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).1. Introduction
Octogenarians comprise the fastest growing segment of the
population, which is expected to double by the year 2030 in Spain.1
In a previous report, the incidence of sepsis among individuals over
85 years of age was 26.2 cases per 1000 population, which is >100-
fold higher than that noted for individuals between 5 and 14 years
of age.2 Thus, the management of sepsis and bacteremia in very old
persons has become a public health concern.
Frequent co-morbidities, long-term institutionalization, declin-
ing functional status, altered immune function, and the increasing
accessibility of healthcare resorts may explain why this population
segment is particularly susceptible to bacterial infections. Fur-
thermore, the mortality rates of most of these infections are at least
three times higher among the elderly than among younger adult
patients with the same disease.3,4 Several host factors are
described as contributing to increased morbidity and mortality:
age-related state of reduced physiological reserve, chronic
underlying diseases, poor tolerance of invasive procedures, poor
response to antimicrobial therapy, and higher rates of adverse
reactions to drugs, including antibiotics.5 There are, however, other
variables leading to worse outcomes, such as a greater risk of
nosocomial infection and delayed diagnosis and therapy, which are
potentially modiﬁable. The clinical presentation of older patients
with sepsis is often atypical, making diagnosis difﬁcult.
Recent evidence has shown that many older patients respond
well to selected interventions when these are initiated in time,6
hence knowledge of the characteristics and predictors of blood-
stream infections (BSI) among the very elderly may lead to a better
and more speciﬁc management of this population. Several studies
have found elderly patients with bacteremia to be at higher risk of
death after controlling for potential confounders.3,7,8 However,
there is little information concerning patients over 80 years of age.
Therefore, the objective of this study was to determine the general
features and independent factors affecting the outcome of BSI
among the very elderly.
2. Methods
We followed the STROBE recommendations for reporting
observational studies.9
2.1. Study design and patient selection
Our study analyzed a prospective cohort that included all
consecutive adult in-patients aged 80 years with clinically
signiﬁcant BSI in 15 public hospitals (10 tertiary and ﬁve
community) in Andalusia, Spain, between October and December
2006 (to March 2007 in community centers). This sub-analysis
forms part of the SAEI/SAMPAC/REIPI Bacteremia Project, the
overall characteristics of which have been published previously.10
In brief, cases were included by daily review of the positive
cultures processed by the microbiology laboratory of eachparticipating center. Blood cultures were performed, processed,
and interpreted in accordance with the recommendations of the
Spanish Society of Infectious Diseases and Clinical Microbiology;11
episodes caused by potential contaminants (such as coagulase-
negative staphylococci) were included only when isolated from at
least two different blood culture sets. Susceptibility results were
interpreted in accordance with the Clinical and Laboratory Standards
Institute (CLSI) recommendations.12 Patients were followed for
30 days by an infectious disease physician, who collected the clinical
data. Centers for Disease Control and Prevention (CDC) criteria were
used to deﬁne the source of bacteremia.13
The study was approved by the Ethics Committee of the
Hospital Universitario Virgen Macarena, which waived the need to
obtain informed consent.
2.2. Variables and deﬁnitions
The data collected included the following: demographics,
acquisition category (nosocomial if the episode occurred more than
48 h after admission, and all other episodes considered as
community-onset, then sub-classiﬁed as healthcare-associated or
community-acquired, according to the criteria used by Friedman
et al.14), type of hospital, ward of admission, presence of underlying
chronic disease and its severity according to the Charlson index,15
vascular or urinary catheter at onset, endoscopic procedures
performed during the preceding week and major surgery in the
preceding 3 months, antimicrobial use in the preceding 3 months,
source of BSI using CDC criteria,13 severity of illness the day before the
onset of bacteremia (day 1) using the Pitt score,16 severity of
systemic inﬂammatory response syndrome (SIRS) according to
predeﬁned criteria on day 0,17 etiology, and treatment. Empirical
therapy (i.e., administered before the susceptibility data were known)
was considered adequate when an active antimicrobial agent (based
on susceptibility data) was administered at the recommended dose
within the ﬁrst 24 h after the blood cultures were performed.
Pathogens were considered multidrug-resistant (MDR) if they
showed acquired non-susceptibility to at least one agent in three
or more antimicrobial categories.18 The outcome variables were
all-cause mortality on day 14 and day 30.
2.3. Statistical analysis
Univariate analyses were performed using the Chi-square test
or Fisher’s exact test and the Student’s t-test and Mann–Whitney
U-test for comparison of categorical and continuous variables,
respectively. The association between different variables and
mortality or inadequate treatment was estimated by calculating
the crude relative risk (RR), with 95% conﬁdence intervals (CI).
Multivariate analyses were performed by logistic regression. All
variables associated with mortality by a conservative univariate
analysis at a level of signiﬁcance of <0.2 were included in the initial
models. Variables were selected using a backward stepwise process;
a p-value of <0.1 was used to delete variables in subsequent steps.
Interactions were investigated. Model validity was evaluated by
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and its discrimination ability using the area under the receiver
operating characteristics (ROC) curve. All analyses were carried out
using SPSS 15.0 software package (SPSS Inc., Chicago, IL, USA).
3. Results
3.1. Patient characteristics, clinical features, etiology, and mortality
One hundred and twenty episodes were included. Demographic,
epidemiologic, clinical, and microbiological data are shown in Table 1.
With respect to BSI acquisition, 53% of episodes were nosocomial, 26%
healthcare-associated, and 21% community-acquired. Of the 31
patients with community-onset healthcare-associated episodes, 20
had been hospitalized during the previous year, ﬁve came from a
nursing home (two of these had also been hospitalized previously), ﬁve
were undergoing hemodialysis (one had also been hospitalized), and
eight had received specialized home care (four of these had also been
hospitalized in the previous year). The most frequent underlying
condition was diabetes (31%, n = 37). Forty-two percent of BSI
patients presented signs with a urinary catheter and 38% had taken
antibiotics in the previous 3 months. The most common sources
of BSI were urinary (26%, n = 31) and unknown (24%, n = 29).Table 1
Characteristics, clinical features, etiology, and mortality of very elderly patients
with bloodstream infections
n (% of 120)
Male gender 58 (48)
Age, years, median (IQR) 83 (5)
Acquisition
Community 25 (21)
Healthcare-related 31 (26)
Nosocomial 64 (53)
Ward of admission when blood cultures were taken
Emergency department 56 (47)
Medical ward 43 (36)
Surgical ward 9 (7)
Intensive care unit 12 (10)
Charlson index, median (IQR) 2 (1)
Pitt score, median (IQR) 1 (2)
Severe sepsis or shock at presentation 33 (27)
Underlying diseases
Cancer 22 (18)
Neutropenia 2 (2)
Diabetes 37 (31)
Chronic pulmonary disease 20 (17)
Renal insufﬁciency 16 (13)
Invasive procedures
Urinary catheter 50 (42)
Nasogastric tube 13 (11)
Previous surgery 13 (11)
Previous antimicrobial use 46 (38)
Source
Unknown 29 (24)
Urinary tract 31 (26)
Intra-abdominal infection 5 (4)
Biliary 17 (14)
Vascular catheter 14 (12)
Respiratory source 13 (11)
Skin and soft tissue infection 8 (7)
Other source 3 (2)
Etiology
Escherichia coli 43 (36)
Staphylococcus aureus 11 (9)
Klebsiella pneumoniae 9 (7)
Enterococcus spp 6 (5)
Coagulase-negative staphylococci 25 (21)
Enterobacter spp 2 (2)
Pseudomonas aeruginosa 5 (4)
Streptococcus pneumoniae 2 (2)
IQR, interquartile range.Regarding the etiology of the BSI, we described 120 episodes of
which seven were polymicrobial. The most common microorgan-
ism was Escherichia coli (36%, n = 43), followed by coagulase-
negative staphylococci (21%, n = 25). Among the latter, 30% were
catheter-related BSI and up to 40% of unknown source; of these,
ﬁve occurred in patients with a peripheral intravenous line. Only
9% of episodes were caused by Staphylococcus aureus (n = 11), and
54% (n = 6) of these were methicillin-resistant. Among Gram-
negative organisms (n = 68), 19% (n = 13) were cefotaxime-
resistant and 37% (n = 25) ﬂuoroquinolone-resistant. One episode
was caused by Bacteroides fragilis but was monomicrobial.
Empiric antimicrobial treatment was adequate in 73% (n = 89)
of episodes. All-cause mortality was 22% (n = 26) on day 14 and 28%
(n = 33) on day 30.
3.2. Variables associated with 14- and 30-day mortality
An analysis of the demographics, epidemiological and clinical
factors associated with 14- and 30-day mortality in very elderly
patients with BSI is set out in Table 2. In the univariate analysis, 14-
day mortality was signiﬁcantly higher when the patient presented
with neutropenia, had had a surgical procedure in the previous
month, a Pitt score 2, severe sepsis or shock, or the patient had
been admitted to the ICU (43% vs. 19%, p = 0.04). Similar variables
were associated with mortality on day 30. On day 14, mortality in
tertiary hospitals was 24% and in community hospitals was 16%
(p = 0.33); on day 30 these percentages were 29.5% and 25%,
respectively (p = 0.62). No signiﬁcant differences were found.
Regarding the etiology, there was higher mortality for episodes
caused by Gram-positive microorganisms compared to Gram-
negative microorganisms (26% vs. 16% on day 14, and 32% vs. 23%
on day 30), although the differences were not statistically
signiﬁcant. There was only one episode caused by a fungus and
one by an anaerobic microorganism and both patients died before
day 14. The mortality rates on days 14 and 30, respectively, among
the most prevalent pathogens were: E. coli, 14% and 23%;
coagulase-negative staphylococci, 24% and 28%; S. aureus, 18%
and 36%; and Klebsiella pneumoniae, 0.
We also analyzed the prevalence of antimicrobial-resistant
pathogens and their association with mortality; 13% of episodes
(n = 16) were caused by resistant pathogens. On days 14 and 30,
mortality rates for multidrug-resistant (MDR) pathogens were 25%
and 32%, respectively, and for non-MDR, 21% and 25%, respectively.
The differences were not signiﬁcant. Among Gram-negatives,
mortality was higher when the microorganism was resistant to
cefotaxime (23% vs. 14% on day 14, and 31% vs. 22% on day 30) or
was ﬂuoroquinolone-resistant (25% vs. 12% on day 14, and 40% vs.
17% on day 30), although these differences were not signiﬁcant.
Mortality rates associated with the source of BSI are shown in
Figure 1. The lowest mortality rates on day 14 occurred for urinary
(10%), catheter-related (14%), and biliary sources (18%). These
sources were categorized as ‘low-risk sources’ for the multivariate
analysis. The highest mortality rates were seen in intra-abdominal
infections other than biliary (40%) and in patients with an
unknown source (35%).
An exploratory multivariate analysis of variables associated
with 14- and 30-day mortality was then performed. The variables
introduced in the logistic regression models were: neutropenia, a
surgical procedure in the previous month, Pitt score 2, severe
sepsis or shock, ICU admission, high-risk BSI, and inadequate
empirical treatment. Interactions between empirical treatment
and source, Pitt score 2, and severity of SIRS were also studied.
Variables independently associated with mortality on day 14 were
the following: high-risk source (odds ratio (OR) 7.9, 95% CI 1.8–
33.9), Pitt score 2 (OR 5.6, 95% CI 1.3–23.3), inadequate empirical
treatment (OR 11.24, 95% CI 1.6–80.2), and severe sepsis or shock
Table 2
Univariate analysis of demographics, predisposing factors, clinical factors, and etiology related to mortality on days 14 and 30
Variable No. deaths on day
14 /No. exposed (%)
RR (95% CI) p-Value No. deaths on day
30/No. exposed (%)
RR (95% CI) p-Value
Type of acquisition
Community 8/25 (32) 2.0 (0.7–5.3) 0.2 10/25 (40) 1.8 (0.8–4.0) 0.2
Healthcare-related 5/31 (16) Ref. - 7/31 (23) Ref. -
Nosocomial 13/64 (20) 1.3 (0.5–3.2) 0.6 17/64 (27) 1.2 (0.6–1.5) 0.7
Charlson score 2
No 11 /56 (20) Ref. 15/56 (27) Ref.
Yes 15/64 (23) 1.2 (0.6–2.4) 0.6 19/64 (30) 1.5 (0.8–2.9) 0.2
Neutropenia
No 24/118 (20) Ref. 32/118 (27) Ref.
Yes 2/2 (100) 4.9 (3.4–7.0) 0.04 2/2 (100) 3.7 (2.7–4.9) 0.02
Previous surgery
No 19/107 (18) Ref. 25/107 (23) Ref.
Yes 7 /13 (54) 3.0 (1.6–5.8) 0.003 9/13 (69) 3.0 (1.8–4.9) 0.001
Previous antibiotics
No 16/73 (22) Ref. 21/73 (29) Ref.
Yes 10/46 (22) 1.0 (0.5–2.0) 1 13/46 (28) 1.0 (0.5–1.8) 1
Urinary catheter
No 13/70 (19) Ref. 16/70 (23) Ref.
Yes 13/50 (26) 1.4 (0.7–2.8) 0.3 18/50 (26) 1.6 (0.9–2.8) 0.1
Pitt score
0–1 4/69 (6) Ref. 9/69 (13) Ref.
2 22/51 (43) 7.4 (2.7–20.3) <0.001 25/51 (49) 3.8 (1.9–7.3) <0.001
ICU admission
No 20/106 (19) Ref. 27/106 (25) Ref.
Yes 6/14 (43) 2.3 (1.1–4.7) 0.04 7/14 (50) 2.0 (1.1–3.6) 0.06
Severity of SIRS
Sepsis 9/88 (10) Ref. 15/88 (17) Ref.
Severe sepsis or septic shock 17/32 (53) 5.2 (2.6–10.4) <0.001 19/32 (59) 3.5 (2.0–6.0) <0.001
Empiric therapy
Adequate 16/88 (18) Ref. 23/88 (26) Ref.
Inadequate 10/32 (31) 1.7 (0.7–3.4) 0.1 11/32 (34) 1.3 (0.7–3.4) 0.4
RR, relative risk; CI, conﬁdence interval; Ref., reference; ICU, intensive care unit; SIRS, systemic inﬂammatory response syndrome.
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empirical treatment and a high-risk source was signiﬁcant (p =
0.06). In this model, the p-value for the Hosmer–Lemeshow
goodness-of-ﬁt test was 0.58, with an area under the ROC curve of
0.87 (meaning good predictive ability). On day 30, mortality was
independently related to a high-risk source (OR 2.92, 95% CI 1.1–
7.5) and presentation with severe sepsis or shock (OR 3.81, 95% CI
1.2–12.4). The Hosmer–Lemeshow goodness-of-ﬁt test was 0.27
for this model, with an area under the ROC curve of 0.77 (meaning
moderate predictive ability).
4. Discussion
We described the features of patients aged 80 years with
bacteremia and identiﬁed predictors of short-term mortality. Some
features of the population are remarkable. In our cohort, 26% of the
episodes were community-onset healthcare-associated and 53%
were nosocomial. In some earlier studies in this population,0 
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Figure 1. Mortality rates according to the source of bloodstream infection; gray bars
indicate 14-day mortality, black bars indicate 30-day mortality.community acquisition was the most common, although the
healthcare-associated category was not taken into account in
some of these studies.19 Previous or present care in healthcare
facilities may facilitate the acquisition of exogenous bacteria,
and invasive procedures, which are increasingly being per-
formed in very old people, may compromise the natural barriers
of innate immunity and create a portal of entry for healthcare-
acquired and nosocomial BSI. However, because of the unspeciﬁc
clinical presentation of sepsis in the very elderly, some true
community BSI may have been misclassiﬁed as nosocomial due
to delayed diagnosis. It is essential to make a careful evaluation
of older patients for subtle signs of systemic inﬂammatory
response syndrome, since such patients pose particular chal-
lenges for the diagnosis of sepsis. They are often initially
diagnosed as having delirium, weakness, anorexia, malaise,
urinary incontinence, or falls,5,6 which are common clinical
expressions of infection in elderly patients. In one recent study,
fever was blunted or absent in half of the elderly patients
studied.19
Regarding co-morbidity, the median Charlson index score was
2. Previous studies have observed higher Charlson scores in
patients with BSI aged between 65 and 80 years compared to those
older than this.19,20 This may be explained in terms of a natural
selection of healthier patients, although the possibilities of a
selection bias due to limited diagnostic effort (including blood
cultures) in the very elderly with a worse basal status cannot be
ruled out.
Another feature of note is that 41% of patients with a BSI had a
permanent urinary catheter and the most frequent source of
bacteremia, as expected, was the urinary tract;6,19,20 this is
concordant with the fact that E. coli was the most prevalent
pathogen, followed by coagulase-negative staphylococci, which
also highlights the importance of catheter-related BSI.
P. Retamar et al. / International Journal of Infectious Diseases 26 (2014) 83–87 87In terms of prognosis, mortality rates were 22% and 28% on
days 14 and 30, respectively, higher than the mortality rates found
in the all-ages cohort reported previously (18% and 22%,
respectively).3 Of note, only two patients were neutropenic and
both died. Neutropenia has been shown previously to be
associated with a worse prognosis in BSI in all age populations21
and also in the elderly.19 We also observed a high mortality rate
when the BSI was due to a cefotaxime- or quinolone-resistant
Gram-negative organism, but according to the multivariate
analysis, this effect is more probably due to inadequate therapy.
The high rate of previous antimicrobial use in our cohort should be
mentioned as a potentially modiﬁable predictor of emerging
resistance.22–24
In the multivariate analysis, apart from the variables represent-
ing acute severity of illness (severe sepsis or shock and Pitt score),
we found inadequate empirical antimicrobial treatment to be a
very strong independent predictor of early mortality. The
interaction between empirical therapy and source indicated that
the inﬂuence of empiric therapy was even more relevant when the
source of bacteremia was classiﬁed as high-risk. It has been
reported previously that in cases of urinary, catheter, or biliary
infection, a high concentration of antibiotics in urine or other
interventions, such as device removal, drainage, or are determi-
nant in terms of the outcome.25,26 On the other hand, abdominal,
respiratory, and unknown sources have been related with a worse
outcome in several studies.27,28
This study has several limitations. This was an observational
study and thus subject to potential bias in the associations.
However, our patients were followed prospectively and carefully,
which is critical for the proper classiﬁcation of exposure and
outcome. We suspect that atypical clinical manifestations in the
very elderly may have led to a delay in diagnosis and misclassiﬁ-
cation of the acquisition type, and may possibly have inﬂuenced
the treatment and prognosis; this was not controlled in our study.
The sample size, although similar to those of previous studies,19,20
was insufﬁcient to determine an association between some
variables and mortality. Data regarding long-term (e.g. 3-month)
survival, quality of life after sepsis, and nursing home require-
ments, were not considered. Future research efforts may be
directed towards clarifying these aspects.
In conclusion, we described predictors of early mortality among
very elderly patients with BSI. Inadequate empirical antimicrobial
treatment was an important predictor of survival, particularly in
high-risk sources. The early detection of sepsis and identiﬁcation of
risk factors for resistant organisms present challenges in these
patients, and would contribute to better treatment and outcomes
for the very elderly.
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